Literature DB >> 10449650

Mitochondrial DNA mutations in patients with orthostatic hypotension.

F Schwartz1, C T Baldwin, J Baima, H Gavras.   

Abstract

We determined the entire sequence of the mitochondrial genome in affected individuals from three families with idiopathic orthostatic hypotension. The disorder in two of these families was recently linked to chromosome arm 18q, while the third family remains unlinked. In all three families, orthostatic hypotension is inherited through the females, suggesting the existence of additional contributing factors, such as genomic imprinting or a mitochondrial modifier. We now report the presence of multiple point mutations in the mitochondrial DNA (mtDNA) in all three families. While most of the changes are common polymorphisms, several novel mutations were found that merit further consideration. In one individual, we detected a T-to-C transition at position 1243 in the 12SrRNA, a change from threonine to alanine at position 67 of the ND1 protein, and from valine to isoleucine at position 197 of the ND2 protein. A second individual harbored a novel substitution of threonine with serine at position 536 of the ND5 protein. Two previously unreported amino acid replacements were detected in a third individual: amino acid 193 of cytochrome b was changed from alanine to threonine, and amino acid 88 of COIII was changed from threonine to alanine. Further studies are required to assess the role of these mutations in blood pressure homeostasis. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449650     DOI: 10.1002/(sici)1096-8628(19990910)86:2<145::aid-ajmg11>3.0.co;2-f

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

1.  What is a 'novel' mtDNA mutation--and does 'novelty' really matter?

Authors:  Hans-Jürgen Bandelt; Antonio Salas; Claudio M Bravi
Journal:  J Hum Genet       Date:  2006-10-05       Impact factor: 3.172

2.  The C-1021T polymorphism of dopamine β-hydroxylase is not associated with orthostatic hypotension in a Chinese population.

Authors:  N Lu; J Chen; Y Yuan; X Cong; Y Yang; L Meng; K Sun; R Hui; Y Zheng
Journal:  J Hum Hypertens       Date:  2014-07-03       Impact factor: 3.012

3.  Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients.

Authors:  Xiao-han Fan; Yi-bo Wang; Hu Wang; Kai Sun; Wei-li Zhang; Xiao-dong Song; Jing-zhou Cheng; Hai-ying Wu; Xiang-liang Zhou; Ru-tai Hui
Journal:  Acta Pharmacol Sin       Date:  2009-08-17       Impact factor: 6.150

4.  Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits.

Authors:  Chunyu Liu; Qiong Yang; Shih-Jen Hwang; Fengzhu Sun; Andrew D Johnson; Orian S Shirihai; Ramachandran S Vasan; Daniel Levy; Faina Schwartz
Journal:  Hypertension       Date:  2012-09-04       Impact factor: 10.190

5.  Orthostatic blood pressure dysregulation and polymorphisms of β-adrenergic receptor genes in hypertensive patients.

Authors:  Ying Gao; Yahui Lin; Kai Sun; Yibo Wang; Jingzhou Chen; Hu Wang; Xianliang Zhou; Xiaohan Fan; Rutai Hui
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-02-19       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.